Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Nevada
| Provider | Medicare | Services |
|---|---|---|
| Md Spine Solutions Llc | $171.31 | 18 |
Nevada Pricing in Context
In Nevada, CPT code 81335 (Gene Analysis (thiopurine S-Methyltransferase) For Common Variant) carries an average Medicare payment of $171.31 — 0% above the national benchmark of $171.14. 2 providers across the state submitted claims for this procedure in 2023, performing 19 total services. Individual payments in NV ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Nevada is $195.39, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Nevada sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Urinalysis procedures, the estimated commercial insurance price in Nevada lands near $411.14, with self-pay cash prices typically around $182.22. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Gene Analysis (thiopurine S-Methyltransferase) For Common Variant cost in Nevada?
The average Medicare payment for Gene Analysis (thiopurine S-Methyltransferase) For Common Variant in Nevada is $171.31, which is 0% above the national average of $171.14. Providers in NV typically bill $195.39 for this procedure.
What does Gene Analysis (thiopurine S-Methyltransferase) For Common Variant cost with insurance in Nevada?
With commercial insurance in Nevada, Gene Analysis (thiopurine S-Methyltransferase) For Common Variant costs an estimated $411.14. Without insurance, the estimated cash price is $182.22. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Gene Analysis (thiopurine S-Methyltransferase) For Common Variant in Nevada?
2 providers in Nevada billed Medicare for Gene Analysis (thiopurine S-Methyltransferase) For Common Variant in 2023, performing 19 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Gene Analysis (thiopurine S-Methyltransferase) For Common Variant cheaper in Nevada than the national average?
No — Gene Analysis (thiopurine S-Methyltransferase) For Common Variant costs 0% above the national average in Nevada. The state average Medicare payment is $171.31 compared to $171.14 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.